McGrath et al. (2026)
- Authors: Simon J. McGrath, Charles B. Hillier, Joshua J. Dibble, Trude Schei, Arild Angelsen, Audrey A. Ryback
- Institutes: Action for ME, Bristol, UK, MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK, Norwegian ME Association, Oslo, Norway, School of Economics and Business, Norwegian University of Life Sciences, Ås, Norway
- Publisher: Oxford Open Immunology
- Link: DOI
Summary
This large-scale study confirms that ME/CFS onset occurs in two distinct age waves, suggesting that different biological or environmental factors may drive the disease at different life stages. The finding that early-onset cases are significantly more severe and more likely to be triggered by infections provides crucial evidence for tailoring research and clinical support toward younger patients. Furthermore, the link to affected relatives in the early-onset group highlights a potential genetic component that is more prominent in pediatric and adolescent cases.
What was researched?
The researchers investigated whether the age at which patients develop ME/CFS follows a specific pattern across different European populations. They also explored if the age of onset correlates with disease severity, specific triggers like infections, or a family history of the condition.
Why was it researched?
Previous data from Norway suggested that ME/CFS might have two peaks of incidence rather than a single one. Understanding these patterns is vital for identifying different disease subtypes and clarifying the underlying causes of the illness.
How was it researched?
The study analyzed survey responses from over 9,000 patients with ME/CFS across 10 European countries. These findings were then validated using a separate large dataset from the United Kingdom to ensure the observations were consistent and statistically significant.
What has been found?
The study identified a clear bimodal distribution with an early onset peak at age 16 and a late onset peak at age 36. Early-onset cases were twice as likely to result in severe or very severe disability compared to late-onset cases. Additionally, early onset was strongly associated with infectious triggers, particularly glandular fever, and a higher prevalence of first-degree relatives with the same condition.
Discussion
A key strength is the consistent pattern found across multiple countries and large datasets. However, the study relies on self-reported survey data, which may introduce recall bias regarding the exact age of onset. These findings emphasize that adolescent-onset ME/CFS may represent a distinct clinical phenotype with a higher burden of illness.
Conclusion & Future Work
ME/CFS incidence peaks in adolescence and early middle age, with early onset representing a more severe disease form. Future research should investigate the specific genetic and immunological factors that make adolescents particularly vulnerable to severe, infection-triggered disease.